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Antibiotic Resistance
Antibiotic resistance is an ongoing evolutionary process that has been the concern
of infectious disease specialists since antibiotic use gained popularity. Antibiotic
resistance is not a concern of the public as reflected by their desire for antibiotics
whenever illness occurs. Patients can and do pressure their physicians for antibi-
otics; 12 million antibiotic prescriptions were filled for upper respiratory tract
infections and bronchitis in 1992 (Gonzales R, et al. JAMA 278:901, 1997). Many
physicians disregard the emergence of resistance as a phenomenon that occurs, but
is not found, in their community or hospital and therefore is not a real concern.
Antibiotic resistance is extremely costly. There is an increase in morbidity,
prolonged hospitalization, the ability for infections to be disseminated to other
individuals, and the loss of human life. There is no doubt that the evolutionary
process is continuous in hospitals and communities. The umbrella of community
includes both cities and rural farming areas. Farmers use tremendous quantities of
antibiotics in crop production and raising livestock. This usage exerts significant
selective pressure on bacteria in the environment, which eventually make their
way to humans.
The response to this problem has not been to develop monitoring systems, but
to introduce new broad-spectrum antibiotics. Following the latter is folly since
bacteria have demonstrated, again and again, their ability to overcome new agents
by mutation. In addition, gram-negative bacteria have the ability to transfer resis-
tance to other bacteria, even between different genera. This was revealed when
gram-negative bacteria adapted to beta-lactamases. Forestalling the evolutionary
process can be achieved by reducing the selective pressure by limiting exposure to
antibiotics.
William and Heyman (Science 279:1153-1154, 1988) suggested that progress in
the development of antibiotic resistance can be accomplished by the following:
appropriate human use of antibiotics, decrease or eliminate use of antibiotics for
nonhuman indications, and containment of resistant strains in medical facilities.
Perhaps an opportunity is at hand to develop a systemwide monitoring program for
the infectious disease specialists in obstetrics and gynecology. This appears to be
an ideal opportunity for the two societies, IDSOG and IIDSOG, to develop a
program for monitoring antibiotic usage as well as educating physicians and pa-
tients in their appropriate use.
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